1. Home
  3. Invest

Partner with Purpose

NeOncoFRAx is reshaping cancer immunotherapy—starting with personalized vaccines for pancreatic cancer and evolving toward broader solid tumor care. The company focuses on investing in science, infrastructure, and, above all, the best patient outcome.

We invite you to join us in delivering therapies that are not only effective but ethically grounded, academically driven, and broadly accessible. Unlike traditional biotech, we are not driven by profit margins or patents, but by measurable impact on patients' lives.

NeOncoFRAx

Why Your Support Matters

Your contribution helps bring personalized medicine out of the lab and into the clinic:

  • Enabling development from sequencing to synthesis through close collaboration with Erasmus MC
  • Supporting ethically governed, academically managed trials
  • Accelerating access to life-saving treatments for high-need cancers

Opportunities for Engagement

  • Strategic support for infrastructure, production, and clinical integration
  • Philanthropic partnerships and legacy naming opportunities
  • Joint research collaborations in immunology, oncology, or data science
  • Invitations to closed-door scientific briefings and clinical insights

Recognition & Impact

Supporters may be invited to participate in clinical milestone updates, scientific symposia, or public recognition initiatives.

Contact Us

To explore partnership opportunities, please contact:

Investor Inquiries - Duko Drijfhout (Director NeOncoFRAx)
duko@neoncofrax.com
General Inquiries - Casper van Eijck (Jr.) (General Program Manager)
contact@neoncofrax.com